v3.21.1
Consolidated Balance Sheets - USD ($)
Feb. 28, 2021
Nov. 30, 2020
Current Assets    
Cash and cash equivalents $ 11,277,811 $ 10,361,125
Marketable securities 85,900 88,476
Accounts receivable (net of allowance for doubtful accounts of $2,807,822 and $2,781,668, respectively) 5,638,992 6,322,960
Prepaid expenses 510,652 611,627
Inventory, current portion 868,258 927,318
Other current assets 314,724 244,696
Total current assets 18,696,337 18,556,202
Property and Equipment-net 1,597,180 1,640,774
Other Assets    
Duke license agreement 58,270,522  
Intangible assets, net 1,554,081 1,181,588
Inventory, net of current portion 11,013,166 11,064,034
Goodwill 1,941,411 1,941,411
Deferred tax assets 10,363,967 10,363,967
Operating lease right-of-use asset 1,012,539 299,089
Deposits and other assets, net 507,258 495,029
Total other assets 84,970,944 26,003,118
Total assets 105,264,461 46,200,094
Current Liabilities    
Accounts payable 860,132 957,390
Accrued expenses 3,457,298 2,898,211
Current portion of note payable 3,100,000 3,100,000
Current portion of operating lease liability 239,330 275,570
Current portion of Duke license agreement liability 13,307,094  
Deferred revenue 8,880,930 9,183,450
Total current liabilities 29,844,784 16,414,621
Other Liabilities    
Deferred revenue, net of current portion 27,950,810 27,200,910
Contingent consideration 1,662,246 1,509,852
Note payable, net of current portion and debt issuance costs 1,085,896 2,841,214
Operating lease long-term liability 774,438 23,632
Long-term liability - revenue sharing agreements 875,000 875,000
Total other liabilities 77,114,782 32,450,608
Total liabilities 106,959,566 48,865,229
Commitments and contingencies (Note 9) 0 0
Stockholders' Deficit    
Preferred stock 0 0
Common stock ($.01 par value, 20,000,000 authorized; 13,658,938 issued and 7,570,913 outstanding as of February 28, 2021 and 13,633,638 issued and 7,545,613 outstanding as of November 30, 2020) 136,589 136,336
Additional paid-in capital 36,857,787 36,581,600
Treasury stock, at cost (20,563,357) (20,563,357)
Accumulated deficit (18,126,124) (18,819,714)
Total stockholders' deficit (1,695,105) (2,665,135)
Total liabilities and stockholders' deficit 105,264,461 46,200,094
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock 0 0
Tianhe Stem Cell Biotechnologies Inc [Member]    
Other Assets    
Investment - Tianhe stock 308,000 308,000
Patent Option Agreement [Member]    
Other Assets    
Investment - Tianhe stock   $ 350,000
Duke University [Member]    
Other Liabilities    
Duke license agreement liability $ 44,766,392  

Source